tiprankstipranks
Cascades (TSE:CAS)
TSX:CAS
Want to see TSE:CAS full AI Analyst Report?

Cascades (CAS) AI Stock Analysis

221 Followers

Top Page

TSE:CAS

Cascades

(TSX:CAS)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 5.2)
Rating:60Neutral
Price Target:
C$12.50
▲(15.00% Upside)
Action:Reiterated
Date:05/09/26
The score is driven primarily by improving profitability and stronger free cash flow trends, tempered by elevated leverage and a sharp TTM revenue decline. Valuation is a meaningful support (low P/E and solid dividend yield), while technical indicators remain weak (below key moving averages with negative MACD), limiting the overall score.
Positive Factors
Improving cash generation
Cascades' shift to consistently positive free cash flow is a durable improvement in cash-generation ability. Reliable FCF supports reinvestment in plants, service of debt, and dividend funding, improving resilience to cyclic demand and enabling strategic flexibility over the next several quarters.
Negative Factors
Elevated leverage
Leverage persistently above equity leaves Cascades financially constrained in a cyclical packaging sector. Elevated debt increases interest and refinancing risk, limits capacity for opportunistic capex or M&A, and reduces margin for error if revenue or cash flow weakens over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving cash generation
Cascades' shift to consistently positive free cash flow is a durable improvement in cash-generation ability. Reliable FCF supports reinvestment in plants, service of debt, and dividend funding, improving resilience to cyclic demand and enabling strategic flexibility over the next several quarters.
Read all positive factors

Cascades (CAS) vs. iShares MSCI Canada ETF (EWC)

Cascades Business Overview & Revenue Model

Company Description
Cascades Inc. is a prominent North American manufacturer, converter, and distributor specializing in a diverse range of packaging and tissue paper products. The company's operations are strategically divided into three key business units: Containe...
How the Company Makes Money
Cascades makes money primarily by manufacturing and selling paper-based packaging and tissue products. A major revenue stream comes from its containerboard and corrugated products business, where it produces containerboard and converts it into cor...

Cascades Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Jul 30, 2026
Earnings Call Sentiment Positive
The earnings call indicates a strong performance in Q3 2025, with significant improvements in both the Packaging and Tissue segments, as well as successful debt reduction efforts. However, there are concerns regarding environmental and restructuring costs, along with a cautious outlook for Q4 due to potential demand fluctuations.
Positive Updates
Stronger Than Expected Q3 Performance
Cascades' Q3 2025 performance was stronger than projections, driven by improved volumes, higher average selling prices, and lower production costs. Consolidated EBITDA increased by 16% from Q2 and 14% year-over-year.
Negative Updates
Environmental and Restructuring Costs
Operating income was impacted by $12 million due to a $10 million environmental provision related to a plant closure in Canada and $6 million of restructuring charges mainly from the Niagara Falls mill closure.
Read all updates
Q3-2025 Updates
Negative
Stronger Than Expected Q3 Performance
Cascades' Q3 2025 performance was stronger than projections, driven by improved volumes, higher average selling prices, and lower production costs. Consolidated EBITDA increased by 16% from Q2 and 14% year-over-year.
Read all positive updates
Company Guidance
During the Cascades' Third Quarter 2025 Financial Results Conference Call, the company provided detailed guidance regarding its performance and future expectations. The company reported a consolidated EBITDA of $159 million, which marked a 16% increase from Q2 and a 14% year-over-year increase. Specific to the Packaging segment, Q3 EBITDA increased by 14% sequentially to $136 million, with an improvement in EBITDA margins to 17.1%. The Tissue business also showed strength, with a 21% sequential increase in EBITDA to $46 million. For Q4, Cascades anticipates favorable trends in raw material and selling prices for Packaging, although demand levels are expected to be stable to 10% below Q3 levels due to seasonality and economic uncertainty. The company also highlighted a reduction in net debt by $81 million during Q3, reflecting stronger cash flow from operations, with a leverage ratio decrease to 3.6x. Capital expenditures are projected to be slightly lower than previous estimates for 2025, with expectations set at approximately $140 million. Additionally, Cascades aims to achieve $100 million in run rate profitability improvements by the end of 2026 through ongoing initiatives.

Cascades Financial Statement Overview

Summary
Mixed fundamentals: profitability and operating performance have improved materially versus 2022–2024, with TTM returning to positive net income and stronger operating earnings. Cash generation is a key positive with solid TTM operating cash flow and free cash flow, continuing a shift from negative FCF in 2021–2022 to consistently positive FCF in 2023–TTM. Offsetting this, TTM revenue shows a sharp decline versus the prior period and leverage remains elevated (debt modestly above equity), which increases sensitivity to demand and margin pressure.
Income Statement
56
Neutral
Balance Sheet
48
Neutral
Cash Flow
63
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue4.75B4.78B4.70B4.64B4.47B3.96B
Gross Profit895.00M565.00M1.85B1.66B1.63B491.00M
EBITDA527.00M556.00M392.00M330.00M273.00M281.00M
Net Income102.00M70.00M-31.00M-76.00M-14.00M-47.00M
Balance Sheet
Total Assets4.74B4.67B5.00B4.77B5.05B4.57B
Cash, Cash Equivalents and Short-Term Investments85.00M52.00M28.00M54.00M111.00M175.00M
Total Debt1.99B1.94B2.12B1.94B2.07B1.52B
Total Liabilities2.95B2.92B3.23B2.99B3.13B2.64B
Stockholders Equity1.76B1.72B1.72B1.74B1.87B1.88B
Cash Flow
Free Cash Flow305.00M227.00M88.00M159.00M-362.00M-90.00M
Operating Cash Flow449.00M379.00M272.00M510.00M144.00M211.00M
Investing Cash Flow30.00M-94.00M-150.00M-332.00M-486.00M-247.00M
Financing Cash Flow-423.00M-263.00M-149.00M-225.00M272.00M-529.00M

Cascades Technical Analysis

Technical Analysis Sentiment
Positive
Last Price10.87
Price Trends
50DMA
10.76
Positive
100DMA
11.31
Positive
200DMA
11.35
Positive
Market Momentum
MACD
0.27
Negative
RSI
69.00
Neutral
STOCH
88.58
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CAS, the sentiment is Positive. The current price of 10.87 is below the 20-day moving average (MA) of 11.03, above the 50-day MA of 10.76, and below the 200-day MA of 11.35, indicating a bullish trend. The MACD of 0.27 indicates Negative momentum. The RSI at 69.00 is Neutral, neither overbought nor oversold. The STOCH value of 88.58 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CAS.

Cascades Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
C$15.83B20.1114.41%1.46%4.34%-4.98%
67
Neutral
C$2.51B13.6710.32%7.11%-2.26%-7.15%
65
Neutral
C$483.27M1.3422.24%8.22%-29.78%88.96%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
60
Neutral
C$1.19B11.605.95%3.90%0.02%
60
Neutral
C$309.66M14.9010.96%5.99%-47.22%
58
Neutral
C$88.81M8.289.93%19.66%0.50%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CAS
Cascades
11.84
3.31
38.84%
TSE:RIC
Richards Packaging
28.38
-3.18
-10.09%
TSE:SXP
Supremex
3.66
0.45
14.16%
TSE:TCL.B
Transcontinental Inc. Class B
7.47
3.42
84.58%
TSE:WPK
Winpak
43.15
-1.29
-2.89%
TSE:CCL.B
CCL Industries
92.29
14.17
18.13%

Cascades Corporate Events

Business Operations and StrategyFinancial Disclosures
Cascades Cuts Q1 2026 Outlook but Reaffirms Longer-Term Profit Targets
Negative
Apr 10, 2026
Cascades will report its first-quarter 2026 results on May 7 and has cut its outlook for adjusted EBITDA to a range of $115 million to $120 million, down from a prior forecast of $130 million to $142 million. Management cited weather-related disru...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 09, 2026